PLATINUM Long Lesion clinical results presented at TCT show no cardiac death, heart attach or stent thrombosis at one year NATICK, MA and SAN FRANCISCO, CA -- Boston Scientific Corporation reports ...

12-month clinical data demonstrate low adverse event rates for Boston Scientific's 2.25 mm PROMUS Element Platinum Chromium Stent NATICK, Mass. and PARIS, Boston Scientific Corporation today announced ...

NATICK, Mass. and ATLANTA, March 15 Boston Scientific Corporation (NYSE: BSX) today announced 12-month results from its PERSEUS clinical program that demonstrated positive safety and efficacy outcomes ...

Platinum group elements (PGEs) are a set of precious metals that have become increasingly significant in environmental systems due to their widespread industrial use and distinctive chemical ...

NATICK, Mass., May 12 Boston Scientific Corporation (NYSE: BSX) today announced it has received CE Mark approval for its TAXUS® Element(TM) Paclitaxel-Eluting Coronary Stent System, the Company's ...

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 7, 2012) - Minfocus Exploration Corp. (MFX.V) ("Minfocus") is pleased to announce that ongoing sampling of drill core from holes WM12-34 to WM12-37 has ...

The PLATINUM clinical program is evaluating the safety and efficacy of the PROMUS Element Stent in five multi-center studies totaling more than 1,800 patients, including a randomized controlled trial ...

High-grade gold plus platinum group elements values have also been reported from drilling and surface samples at the Chrome and Iron Mountain deposit areas in addition to large-scale nickel, copper ...